New Key Statistics Module, Z-Score and F-Score
NYSE:HAE Key Ratios
Market Cap $ M | 3,752.10 |
Enterprise Value $ M | 4,688.06 |
P/E(ttm) | 32.88 |
PE Ratio without NRI | 23.17 |
Forward PE Ratio | 15.98 |
Price/Book | 4.14 |
Price/Sales | 2.83 |
Price/Free Cash Flow | 52.99 |
Price/Owner Earnings | 73.66 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,333.00 |
EPS (TTM) $ | 2.23 |
Beneish M-Score | -2.4 |
10-y EBITDA Growth Rate % | 12.10 |
5-y EBITDA Growth Rate % | 6.50 |
y-y EBITDA Growth Rate % | -7.00 |
EV-to-EBIT | 31.05 |
EV-to-EBITDA | 18.44 |
PEG | 3.56 |
Shares Outstanding M | 51.18 |
Net Margin (%) | 8.61 |
Operating Margin % | 11.95 |
Pre-tax Margin (%) | 11.02 |
Quick Ratio | 2.33 |
Current Ratio | 3.76 |
ROA % (ttm) | 5.27 |
ROE % (ttm) | 12.58 |
ROIC % (ttm) | 6.97 |
Dividend Yield % | -- |
Altman Z-Score | 2.68 |
HAE Number of Guru Trades
HAE Volume of Guru Trades
Gurus Latest Trades with NYSE:HAE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:HAE is held by these investors
Total 3
Haemonetics Corp Insider Transactions
No Available Data
News about NYSE:HAE
Total 0- 1